These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9809403)

  • 1. Tolerance and bactericidal action of N-chlorotaurine in a urinary tract infection by an omniresistant Pseudomonas aeruginosa.
    Nagl M; Pfausler B; Schmutzhard E; Fille M; Gottardi W
    Zentralbl Bakteriol; 1998 Oct; 288(2):217-23. PubMed ID: 9809403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic effects of lividomycin in urinary tract infections caused by Pseudomonas aeruginosa].
    Tanaka E; Nakazawa S; Sato H
    Jpn J Antibiot; 1972 Dec; 25(6):446-51. PubMed ID: 4198944
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical use of Kasugamycin for urinary tract infections due to Pseudomonas aeruginosa].
    Ishigami J; Fukuda Y; Hara S
    J Antibiot B; 1967 Apr; 20(2):83-4. PubMed ID: 5299159
    [No Abstract]   [Full Text] [Related]  

  • 4. N-chlorotaurine and its analogues N,N-dichloro-2,2-dimethyltaurine and N-monochloro-2,2-dimethyltaurine are safe and effective bactericidal agents in ex vivo corneal infection models.
    Teuchner B; Eitzinger C; Lutz M; Hager T; Schmid E; Bechrakis NE; Zuck M; Jekle A; Debabov D; Anderson M; Nagl M
    Acta Ophthalmol; 2012 Dec; 90(8):e632-7. PubMed ID: 22971221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bacteriological diagnosis and treatment of urinary tract infection.
    Motzkin D
    J Urol; 1972 Mar; 107(3):454-7. PubMed ID: 4551629
    [No Abstract]   [Full Text] [Related]  

  • 6. Complicated urinary tract infection caused by Pseudomonas aeruginosa in a single institution (1999-2003).
    Shigemura K; Arakawa S; Sakai Y; Kinoshita S; Tanaka K; Fujisawa M
    Int J Urol; 2006 May; 13(5):538-42. PubMed ID: 16771722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical effect of Kasugamycin on urinary tract infections due to Pseudomonas aeruginosa].
    Maekawa A
    J Antibiot B; 1967 Jun; 20(3):197-8. PubMed ID: 4965586
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of kasugamycin in urinary tract infection, especially against Pseudomonas aeruginosa].
    Tada S; Hakamada T; Mori O; Yamazaki Y
    Hinyokika Kiyo; 1968 Jan; 14(1):50-6. PubMed ID: 4971183
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical report of treatment of urinary tract infections with lividomycin].
    Ichikawa T; Nakano I; Hirokawa I; Nakamura M
    Jpn J Antibiot; 1972 Dec; 25(6):389-95. PubMed ID: 4579558
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of complicated urinary tract infection caused by Pseudomonas aeruginosa--a comparison of the efficacy of ceftazidime with that of netilmicin.
    Graninger W; Ho I; Francesconi M; Schmidbauer C; Egger T
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():323-4. PubMed ID: 19803008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis--a double-blind, randomized, phase-2 clinical trial.
    Teuchner B; Nagl M; Schidlbauer A; Ishiko H; Dragosits E; Ulmer H; Aoki K; Ohno S; Mizuki N; Gottardi W; Larcher C
    J Ocul Pharmacol Ther; 2005 Apr; 21(2):157-65. PubMed ID: 15857282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical use of sodium hypochlorite for local treatment and prevention of urinary tract infections and therapy of contracted bladders (author's transl)].
    Eisen M; Jurcovic K; Pfeiffer E; Skoluda D; Busse K
    Urologe A; 1976 Jan; 15(1):39-43. PubMed ID: 176760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin therapy in complicated urinary tract infections caused by Pseudomonas aeruginosa and other resistant bacteria.
    Leigh DA; Emmanuel FX; Petch VJ
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():117-21. PubMed ID: 3542943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciprofloxacin in the treatment of urinary tract infections caused by Pseudomonas aeruginosa and multiresistant bacteria.
    Saavedra S; Ramírez-Ronda CH; Nevárez M
    Eur J Clin Microbiol; 1986 Apr; 5(2):255-7. PubMed ID: 2941296
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of Pseudomonas aeruginosa urinary tract infections with norfloxacin.
    Leigh DA; Emmanuel FX
    J Antimicrob Chemother; 1984 May; 13 Suppl B():85-8. PubMed ID: 6234280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance of N-chlorotaurine, an endogenous antimicrobial agent, in the rabbit and human eye--a phase I clinical study.
    Nagl M; Miller B; Daxecker F; Ulmer H; Gottardi W
    J Ocul Pharmacol Ther; 1998 Jun; 14(3):283-90. PubMed ID: 9671436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid killing of Mycobacterium terrae by N-chlorotaurine in the presence of ammonium is caused by the reaction product monochloramine.
    Nagl M; Gottardi W
    J Pharm Pharmacol; 1998 Nov; 50(11):1317-20. PubMed ID: 9877320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical instillation of amikacin for treatment of a lower urinary tract infection caused by Pseudomonas aeruginosa in a dog.
    Torres AR; Cooke K
    J Am Vet Med Assoc; 2014 Oct; 245(7):809-11. PubMed ID: 25229532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute otitis externa: efficacy and tolerability of N-chlorotaurine, a novel endogenous antiseptic agent.
    Neher A; Nagl M; Appenroth E; Gstöttner M; Wischatta M; Reisigl F; Schindler M; Ulmer H; Stephan K
    Laryngoscope; 2004 May; 114(5):850-4. PubMed ID: 15126742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-acquired Pseudomonas aeruginosa urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and treatment.
    Marcus N; Ashkenazi S; Samra Z; Cohen A; Livni G
    Infection; 2008 Oct; 36(5):421-6. PubMed ID: 18795227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.